Iberogast N

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameIberogast N
Drug Alias NameBAY-98-7410STW-5-II
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsIrritable Bowel SyndromeColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsIrritable Bowel SyndromeColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A